Mayhood T, Kaushik N, Pandey P K, Kashanchi F, Deng L, Pandey V N
Department of Biochemistry and Molecular Biology, UMD-New Jersey Medical School, 185 South Orange Avenue, Newark, New Jersey 07103, USA.
Biochemistry. 2000 Sep 26;39(38):11532-9. doi: 10.1021/bi000708q.
Tat, an essential human immunodeficiency virus type 1 protein interacts with the transactivation response element (TAR) and stimulates transcription from the viral long-terminal repeat (LTR). Blockage of Tat-TAR interaction halts viral transcription and hence replication. We have found that polyamide nucleic acid (PNA), targeted to the TAR sequences of viral RNA genome is able to prevent Tat-TAR interaction by efficient sequestration of the TAR. Anti-TAR PNA competes for TAR and prevents Tat-mediated stimulation of HIV-1 LTR transcription in vitro but has no influence on the basal level of transcription in the absence of Tat. Using a reporter gene construct pHIV LTR-CAT and pCMV-Tat in cell culture, we have further shown that anti-TAR PNA is able to block Tat-mediated transactivation of HIV-1 LTR transcription in vivo as judged by the extent of LTR driven CAT gene expression in the absence and presence of anti-TAR PNA. Supplementation of 100 nM of anti-TAR PNA into the culture medium further enhances the suppression of transactivation. Nonspecific scrambled PNA had no influence on Tat-TAR interaction and LTR-driven CAT gene expression in cell culture. These results suggest that PNA targeted to the TAR sequence of the viral genome may be a potential inhibitor of HIV-1 gene expression.
Tat是人类免疫缺陷病毒1型的一种必需蛋白,它与反式激活应答元件(TAR)相互作用,并刺激病毒长末端重复序列(LTR)的转录。阻断Tat-TAR相互作用会停止病毒转录,从而阻止病毒复制。我们发现,靶向病毒RNA基因组TAR序列的聚酰胺核酸(PNA)能够通过有效隔离TAR来阻止Tat-TAR相互作用。抗TAR PNA可竞争TAR,并在体外阻止Tat介导的HIV-1 LTR转录刺激,但在没有Tat的情况下对基础转录水平没有影响。在细胞培养中使用报告基因构建体pHIV LTR-CAT和pCMV-Tat,我们进一步表明,根据在有无抗TAR PNA的情况下LTR驱动的CAT基因表达程度判断,抗TAR PNA能够在体内阻断Tat介导的HIV-1 LTR转录反式激活。向培养基中补充100 nM的抗TAR PNA可进一步增强对反式激活的抑制作用。非特异性随机排列的PNA对细胞培养中的Tat-TAR相互作用和LTR驱动的CAT基因表达没有影响。这些结果表明,靶向病毒基因组TAR序列的PNA可能是HIV-1基因表达的潜在抑制剂。